Genetic markers of alcohol abuse

Clinica Chimica Acta

Volumn 257, Issue 2, 1997, Pages 199-250

  Ferguson, Ralph A ^a   Goldberg, David M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adenylate cyclase; Alcohol; Alcohol dehydrogenase; Alcoholism; Aldehyde dehydrogenase; Dopamine receptor; Drug dependence; Electroencephalography; Event related brain potential; Gamma aminobutyric acid; Genetics; Inheritance; Monoamine oxidase; Serotonin

Indexed keywords

ADENYLATE CYCLASE; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; AMINE OXIDASE (FLAVIN CONTAINING); GUANINE NUCLEOTIDE BINDING PROTEIN;

ADOPTION; ALCOHOL ABUSE; ALCOHOLISM; ALPHA RHYTHM; CONFERENCE PAPER; DISEASE CLASSIFICATION; ELECTROPHYSIOLOGY; ETHNIC GROUP; FAMILY STUDY; GENETIC MARKER; GENETICS; GENOTYPE; HERITABILITY; HUMAN; INHERITANCE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SIGNAL TRANSDUCTION; TWINS;

ALCOHOLISM; AMINO ACID SEQUENCE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOLECULAR SEQUENCE DATA; QUESTIONNAIRES;

EID: 0031036231     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(96)06444-3     Document Type: Conference Paper

References (232)

1. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;339:464-468.
2. Suh I, Shaten J, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. Ann Intern Med 1992;116:881-887.
3. Renaud SC, Beswick AD, Fehily AM, Sharp DS, Elwood PC. Alcohol and platelet aggregation: the Caerphilly prospective heart disease study. Am J Clin Nutr 1992;55:1012-1017.
4. Goldberg DM, Hahn SE, Parkes JG. Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta 1995;237:155-187.
5. Mendelson JH, Mello NK. The diagnosis and treatment of alcoholism. 2nd edn. New York: McGraw-Hill, 1985.
6. Frances RJ, Franklin J, Flavin DK. Suicide and alcoholism. Ann New York Acad Sci 1986;487:316-326.
7. Miller NS. The pharmacology of alcohol and drugs of abuse and addiction. New York: Springer, 1991.
8. Goldberg DM, Kapur BM. Enzymes and circulating proteins as markers of alcohol abuse. Clin Chim Acta 1994;226:191-209.
9. Dubowski KM. Human pharmacokinetics of alcohol. Alcohol Tech Rep 1976;5:55-63.
10. Bogusc M, Poch J, Stasdo W. Comparative studies on the rate of ethanol elimination in acute poisoning and in controlled conditions. J Forensic Sei 1977;22:446-451.
11. Wagner JG, Wilkinson PK, Sedman AJ, Kay DR, Weidler DJ. Elimination of alcohol from human blood. J Pharm Sci 1976;65:152-154.
12. Winek CL, Murphy KL. The rate and kinetic order of ethanol elimination. Forensic Sci Int 1984;25:159-166.
13. Porter WH, Moyer TP. Clinical toxicology. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry. Philadelphia, PA: Saunders, 1994;1155-1235.
14. Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science 1988;242:715-723.
15. Seller SC. Alcohol abuse in the Old Testament. Alcohol Alcohol 1985;20:69-76.
16. Mathew VM. Alcoholism in Biblical prophecy. Alcohol Alcohol 1992;27:89-90.
17. Scott N. The Fingarette fallacies. Alcohol Addict 1988;8:17-19.
18. Heather N. Why alcoholism is not a disease. Med J Aust 1992;156:212-215.
19. Jurd SM. Why alcoholism is a disease. Med J Aust 1992;156:215-217.
20. Peele S. The implications and limitations of genetic models of alcoholism and other addictions. J Stud Alcohol 1986;47:63-73.
21. Erickson CK. A pharmacologist's opinion - alcoholism: the disease debate needs to stop. Alcohol Alcohol 1992;27:325-328.
22. Wallace J. Controlled drinking, treatment effectiveness, and the disease model of addiction: a commentary on the ideological wishes of Stanton Peele. J Psychoact Drugs 1990;22:261-284.
23. Lewis DC. Comparison of alcoholism and other medical diseases: an internist's view. Psychiatr Ann 1991;21:256-265.
24. Joint Committee of NCADD and ASAM to Study the Definition and Criteria for Diagnosis of Alcoholism. Definition of alcoholism. Washington, DC: National Council on Alcoholism and Drug Dependence Inc.; American Society of Addiction Medicine, 1990.
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd edn., revised. Washington, DC: American Psychiatric Association, 1987.
26. Rounsaville BJ, Spitzer RL, Williams JEW. Proposed changes in DSM-III substance abuse disorders: description and rationale. Am J Psychiatry 1986;143:463-468.
27. Rounsaville BJ, Kosten TR, Williams JBW. Spitzer RL. A field trial of DSM-III-R psychoactive substance dependence disorders. Am J Psychiatry 1987;144:3.
28. Schuckit MA, Zisook S, Mortola J. Clinical implications of DSM-III diagnosis of alcohol abuse and alcohol dependence. Am J Psychiatry 1985;142:12.
29. American Psychiatric Association. Task Force on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders. 3rd edn. Washington, DC: American Psychiatric Association, 1980.
30. Ewing JA. Detecting alcoholism: the CAGE questionnaire. J Am Med Assoc 1984;252:1905-1907.
31. Selzer ML. The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 1971;127:1653-1658.
32. Adams PJ, Stevens V. Are emergency department patients more likely to answer alcohol questions in a masked health questionnaire? Alcohol Alcohol 1994;29:193-197.
33. Walters GD. Greene RL, Jeffrey TB, Kruzich DJ, Haskin JJ. Racial variations on the MacAndrew alcoholism scale of the MMPI. J Consult Clin Psychol 1983;51:947-948.
34. Cherpital CJ. Screening for alcohol problems in the emergency department. Ann Emerg Med 1995;26:158-166.
35. Fleming MF, Barry KL. A three sample test of a masked alcohol screening questionnaire. Alcohol Alcohol 1991;26:81-91.
36. Waterson EJ. Murray-Lyon IM. Asking about alcohol: a comparison of three methods used in an antenatal clinic. J Obstet Gynecol 1988;8:303-306.
37. Storgaard H, Nielsen SD, Gluud C. The validity of the Michigan alcoholism screening test (MAST). Alcohol Alcohol 1994;29:493-502.
38. Babor TF, Dolinsky ZS. Alcoholic typologies: historical evolution and empirical evaluation of some common classification schemes. In: Rose RM, Barrett J, eds. Alcoholism: origins and outcome. New York: Raven Press, 1988;245-266.
39. Babor TF. Method and theory in the classification of alcoholics. Ann New York Acad Sci 1994;708:l-6.
40. Cloninger CR. Neurogenetic adaptive mechanisms in alcoholism. Science 1987;236:410-416.
41. Morey LC, Skinner HA. Empirically derived classification of alcohol-related problems. In: Galanter M. ed. Recent developments in alcoholism. New York: Plenum Press. 1986;5:45-168.
42. Zucker RA. The four alcoholisms: a developmental account of the etiologic process. In: Rivers PC, ed. Alcohol and addictive behavior. Lincoln: University of Nebraska Press, 1987;27-83.
43. Babor TF, Hofmann M, Del Boca F, et al. Types of alcoholic. I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 1992;49:599-608.
44. Brown J, Babor TF, Litt MD, Kranzler HR. The type A/type B distinction: subtyping alcoholics according to indicators of vulnerability and severity. Ann New York Acad Sci 1994;708:23-33.
45. Del Boca FK. Sex, gender and alcoholic typologies. Ann New York Acad Sci 1994;708:34-48.
46. Vrublevsky AG. Variants of alcoholism. Patterns in development, course and prognosis. Ann New York Acad Sci 1994;708:86-96.
47. Zucker RA, Ellis DA, Fitzgerald HE. Developmental evidence for at least two alcoholisms. 1. Biopsychosocial variation among pathways into symptomatic difficulty. Ann New York Acad Sci 1994;708:134-146.
48. Goodwin DW, Knop J, Jensen P, Gabrielli WF, Schulsinger F, Penick EC. Thirty-year follow-up of men at high risk for alcoholism. Ann New York Acad Sci 1994;708:97-101.
49. McCaul ME, Turkkan JS, Svikis DS, Bigelow GE. Alcohol and secobarbitol effects as a function of familial alcoholism: acute psychophysiological effects. Alcohol Clin Exp Res 1990;14:704-712.
50. McCaul ME, Turkkan JS, Svikis DS, Bigelow GE. Alcohol and secobarbitol effects as a function of familial alcoholism: extended intoxication and increased withdrawal effects. Alcohol Clin Exp Res 1991;15:94-101.
51. Newlin DB, Thomson JB. Chronic tolerance and sensitization to alcohol in sons of alcoholics. Alcohol Clin Exp Res 1991;15:399-405.
52. Hill SY, Steinhauer SR, Smith TR, Locke J. Risk markers for alcoholism in high density families. J Subst Abuse 1991;3:351-369.
53. Dinwiddie SH. Patterns of alcoholism inheritance. J Subst Abuse 1992;4:155-163.
54. Vrasti R, Eisemann M, Bucur M. Discriminative features of alcoholics classified according to family history. J Subst Abuse 1993;5:145-155.
55. Cotton NS. The familial incidence of alcoholism: a review. J Stud Alcohol 1979;40:89-116.
56. Merikangas KR. The genetic epidemiology of alcoholism. Psychol Med 1990;20:11-22.
57. Pollock VE, Schneider LS, Gabrielli WF, Goodwin DW. Sex of parent and offspring in the transmission of alcoholism: a meta-analysis. J Nerv Ment Dis 1987;175:668-673.
58. Pandina RJ, Johnson V. Serious alcohol and drug problems among adolescents with a family history of alcoholism. J Stud Alcohol 1990;51:278-282.
59. Knop J, Goodwin DW, Jensen P, et al. A 30-year follow-up study of the sons of alcoholic men. Acta Psychiatr Scand 1993; Suppl 370:48-53.
60. Kendler KS. Indirect vertical cultural transmission: a model for nongenetic parental influence on the liability to psychiatric illness. Am J Psychiatry 1988;145:657-665.
61. Kaij L. Alcoholism in twins: studies on the etiology and sequelae of abuse of alcohol. Stockholm: Alonquist and Winkell, 1960.
62. Hrubec Z, Omenn GS. Evidence of genetic pre-disposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological endpoints among male veterans. Alcohol Clin Exp Res 1981;5:207-215.
63. Murray RM, Clifford C, Gurlin HM. Twin and alcoholism studies. In: Galanter M, ed. Recent developments in alcoholism. Vol. 1. New York: Plenum Press, 1983:25-47.
64. Pickens RW, Svikis DS, McGue M, Lykken DT, Heston LL, Clayton PJ. Heterogeneity in the inheritance of alcoholism: a study of male and female twins. Arch Gen Psychiatry 1991;48:19-28.
65. McGue M, Pickens RW, Svikis DS. Sex and age effects on the inheritance of alcohol problems: a twin study. J Abnorm Psychol 1992;101:3-17.
66. Kendler KS, Heath AC, Neale MC, Kessler RC, Eaves LJ. A population-based twin study of alcoholism in women. J Am Med Assoc 1992;268:1877-1882.
67. Kendler KS, Neale MC, Heath AC, Kessler RC, Eaves LJ. A twin-family study of alcoholism in women. Am J Psychiatry 1994;151:707-715.
68. Marshall EJ, Murray RM. The contribution of twin studies to alcoholism research. In: Goedde HW, Agarwal DP, eds. Alcoholism - biomedical and genetic aspects. New York: Pergamon, 1989;277-289.
69. Schuckit MA, Goodwin DW, Winokur GA. A study of alcoholism in half siblings. Am J Psychiatry 1972;128:1132-1136.
70. Goodwin DW, Schulsinger F, Hermansen L, Guze SB, Winokur G. Alcohol problems in adoptees raised apart from alcoholic parents. Arch Gen Psychiatry 1973;28:238-243.
71. Goodwin DW, Schulsinger F, Møller N, Hermansen L, Winokur G, Guze SB. Drinking problems in adopted and non-adopted sons of alcoholics. Arch Gen Psychiatry 1974;31:164-169.
72. Bohman M, Sigvardsson S, Cloninger CR. Maternal inheritance of alcohol abuse: cross fostering analysis of adopted women. Arch Gen Psychiatry 1981;38:965-969.
73. Bohman M, Cloninger CR, von Knorring A-L, Sigvardsson S. An adoption study of somatoform disorders. III. Cross-fostering analysis and genetic relationships to alcoholism and criminality. Arch Gen Psychiatry 1984;41:872-878.
74. Crabb DW, Dipple KM, Thomasson HR. Alcohol sensitivity, alcohol metabolism, risk of alcoholism, and the role of alcohol and aldehyde dehydrogenase genotypes. J Lab Clin Med 1993;122:234-240.
75. Smith M, Duester G, Carlock L, Wasmuth J. Assignment of ADH1, ADH2, and ADH3 genes (class 1 ADH) to human chromosome 4q21-4q25 through the use of DNA probes. Cytogenet Cell Genet 1985;40:748.
76. Couzigou P, Fleury B, Groppi A, Cassaigne A. Bégueret J, Iron A. Genotyping study of alcohol dehydrogenase class 1 polymorphism in French patients with alcoholic cirrhosis. Alcohol Alcohol 1990;25:623-626.
77. Shibuya A, Yoshida A. Genotypes of alcohol metabolizing enzymes in Japanese with alcohol liver disease: a strong association of the usual caucasian-type aldehyde dehydrogenase gene (ALDH1/2) with the disease. Am J Hum Genet 1988;43:744-748.
78. Couzigou P, Fleury B, Groppi A, et al. Role of alcohol dehydrogenase polymorphism in ethanol metabolism and alcohol related diseases. In: Weiner H, Wermuth B, Crabb DW, eds. Enzymology and molecular biology of carbonyl metabolism 3. New York: Plenum Press, 1990;263-270.
79. Thomasson HR, Edenberg HJ, Crabb DW et al. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet 1991;48:677-681.
80. Thomasson HR, Crabb DW, Edenberg HJ, Li T-K. Alcohol and aldehyde dehydrogenase polymorphisms and alcoholism. Behav Genet 1993;23:131-136.
81. Gilder FJ, Hodgkinson S, Murray RM. ADH and ALDH genotype profiles in Caucasians with alcohol-related problems and controls. Addiction 1993;88:383-388.
82. Sherman DIN, Ward RJ, Warren-Perry M, Williams R, Peters TJ. Association of restriction fragment length polymorphisms in alcohol dehydrogenase 2 gene with alcohol induced liver damage. Br Med J 1993;307:1388-1390.
83. Sherman DIN, Ward RJ, Peters TJ. The role of alcohol and aldehyde dehydrogenases in alcohol-related diseases: clinical studies of molecular markers. In: Weiner H, ed. Enzymology and molecular biology of carbonyl metabolism 4. New York: Plenum Press, 1993;555-560.
84. Sherman DIN, Ward RJ, Yoshida A, Peters TJ. Alcohol and acetaldehyde dehydrogenase gene polymorphism and alcoholism. In: Jansson B, Jörnvall H, Rydberg U, Terenius L, Vallee BL, eds. Toward a molecular basis of alcohol use and abuse. Basle: Birkhäuser, 1994;291-300.
85. Day CP, Bashir R, James OFW et al. Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase gene loci in genetic predisposition to alcohol-related end-organ damage. Hepatology 1991;14:798-801.
86. Ehring T, Bosron W, Li TK. Alcohol and aldehyde dehydrogenase. Alcohol Alcohol 1990;25:105-116.
87. Hsu LC. Yoshida A, Mohandas T. Chromosomal assignment of the genes for human aldehyde dehydrogenase-1 and aldehyde dehydrogenase-2. Am J Hum Genet 1986;38:641-648.
88. Mizoi Y, Kogame M, Fukunaga T, Ueno Y, Adachi J, Fujiwara S. Polymorphisms of aldehyde dehydrogenase and ethanol elimination. Alcohol 1985;2:393-396.
89. Tsukamoto S, Muto T, Nagoya T, Shimamura M, Saito M, Tainaka H. Determinations of ethanol, acetaldehyde, and acetate in blood and urine during alcohol oxidation in man. Alcohol Alcohol 1989;24:101-108.
90. Jones AW. Measuring and reporting the concentration of acetaldehyde in human breath. Alcohol Alcohol 1995;30:271-285.
91. Harada S, Agarwal DP, Goedde HW. Aldehyde dehydrogenase polymorphism and alcohol metabolism in alcoholics. Alcohol 1985;2:391-392.
92. Slutske WS, Heath AC, Madden PA, et al. Is alcohol-related flushing a protective factor for alcoholism in Caucasians? Alcohol Clin Exp Res 1995;19:582-592.
93. Sherman DIN, Dave V, Hsu LC, Peters TJ, Yoshida A. Diverse polymorphism within a short coding region of the human aldehyde dehydrogenase-5 (ALDH5) gene. Hum Genet 1993;92:477-480.
94. Higuchi S, Muramatsu T, Shigemori K et al. The relationship between low Km aldehyde dehydrogenase phenotype and drinking behavior in Japanese. J Stud Alcohol 1992;53:170-175.
95. Higuchi S, Matsushita S, Imazeki H, Kinoshita T. Takagi S, Kono H. Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet 1994;343:741-742.
96. Takeshita T, Morimoto K, Mao X-Q, Hashimoto T, Furyuama J-I. Phenotypic differences in low Km aldehyde dehydrogenase in Japanese workers. Lancet 1993;341:837-838.
97. Enomoto N, Takase S, Yasuhara M, Takada A. Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcohol Clin Exp Res 1991;15:141-144.
98. Tu GC, Israel Y. Alcohol consumption by Orientals in North America is predicted largely by a single gene. Behav Genet 1995;25:59-65.
99. Higuchi S, Matsushita S, Murayama M, Takagi S, Hayashida M. Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiatry 1995;152:1219-1221.
100. Johnston JP. Some observations on a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 1968;17:1285-1297.
101. Knoll J, Magyar K. Some puzzling pharmacological effects of monoamine oxidase inhibition. Adv Biochem Psychopharmacol 1972;5:393-408.
102. White HL, Glassman AT. Multiple binding sites of human brain and liver monoamine oxidase: substrate specificities, selective inhibitors, and attempts to separate enzyme forms. J Neurochem 1977;29:987-997.
103. Donnelley CH, Murphy DL. Substrate and inhibitor-related characteristics of human platelet monoamine oxidase. Biochem Pharmacol 1977;26:853-858.
104. Breakefield XO, Edelstein SB. Inherited levels of A and B types of monoamine oxidase activity. Schizophr Bull 1980;6:282-288.
105. Gottfries CG, Oreland L, Wiberg Å, Winblad B. Lowered monoamine oxidase activity in brains from alcoholic suicides. J Neurochem 1975;25:667-673.
106. Oreland L, Wiberg Å, Winblad B, Fowler CJ, Gottfries CG, Kiianmaa K. The activity of monoamine oxidase A and B in brains from chronic alcoholics. J Neural Transm 1983;56:73-83.
107. Wiberg Å, Gottfries CG, Oreland L. Low platelet monoamine oxidase activity in human alcoholics. Med Biol 1977;55:181-186.
108. Major LF, Murphy DL. Platelet and plasma amine oxidase activity in alcoholic individuals. Br J Psychiatry 1978;132:548-554.
109. Sullivan JL, Stanfield CN, Schanberg S, Cavenar J. Platelet monoamine oxidase and serum dopamine-hydroxylase activity in chronic alcoholics. Arch Gen Psychiatry 1978;35:1209-1212.
110. Alexopoulos GS, Lieberman KW, Frances RJ. Platelet MAO activity in alcoholic patients and their first degree relatives. Am J Psychiatry 1983;140:1501-1504.
111. Giller E, Nocks J, Hall H, Stewart C, Schnitt J. Sherman B. Platelet and fibroblast monoamine oxidase in alcoholism. Psychiatry Res 1984;12:339-347.
112. Wiberg A. Increase in platelet monoamine oxidase activity during controlled abstinence after alcohol abuse. Med Biol 1979;56:133-134.
113. Major LF, Goyer PF, Murphy DL. Changes in platelet monoamine oxidase activity during abstinence. J Stud Alcohol 1981;42:1052-1057.
114. Alexopoulos GS, Lieberman KW, Frances RJ, Stokes PE. Platelet MAO during the alcohol withdrawal syndrome. Am J Psychiatry 1981;138:1254-1255.
115. Schuckit MA, Shaskan E, Duby J, Vega R, Moss M. Platelet monoamine oxidase activity in relatives of alcoholics. Arch Gen Psychiatry 1982;39:137-140.
116. Von Knorring A-L, Bohman M, Von Knorring L, Oreland L. Platelet MAO activity as a biological marker in subgroups of alcoholism. Acta Psychiatr Scand 1985;72:51-58.
117. Pandey GN, Fawcett J, Gibbons R, Clark DC, Davis JM. Platelet monoamine oxidase in alcoholism. Biol Psychiatry 1988;24:15-24.
118. Sullivan JL, Baenziger JC, Wagner DL, Rauscher FP, Nurnberger JI, Holmes JS. Platelet monoamine oxidase in subtypes of alcoholism. Biol Psychiatry 1990;27:911-922.
119. Von Knorring A-L. Hallman J, Von Knorring L. Oreland L. Platelet monoamine oxidase activity in type 1 and type 2 alcoholism. Alcohol Alcohol 1991;6:409-416.
120. Oreland L, Shaskan EG. Monoamine oxidase activity as a biological marker. Trends Pharmacol Sci 1983;4:339-341.
121. Moss HB. Serotonergic activity and disinhibitory psychopathy in alcoholism. Med Hypotheses 1987;23:353-361.
122. Roy A, Linnoila M. Suicidal behaviour, impulsiveness and serotonin. Acta Psychiatr Scand 1988;78:529-535.
123. Roy A, De Jong J, Linnoila M. Cerebrospinal fluid monoamine metabolites and suicidal behaviour in depressed patients. Arch Gen Psychiatry 1989;46:609-612.
124. Devor EJ, Abell CW, Huffman PL, Tabakoff B, Cloninger CR. Platelet MAO activity in type I and type II alcoholism. Ann New York Acad Sci 1994;708:119-128.
125. Seeman P, Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 1975;188:1217-1219.
126. Carmichael FJ, Israel Y. Effects of ethanol on neurotransmitter release by rat brain cortical slices. J Pharmacol Exp Ther 1975;193:824-834.
127. Fadda R, Argiolas A, Melis MR, Serra G, Gessa GL. Differential effect of acute and chronic ethanol on dopamine metabolism in frontal cortex, caudate nucleus and substantia nigra. Life Sci 1980;27:979-986.
128. Imperato A, DiChiara G. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 1986;239:219-228.
129. Kebabian JW, Greengard P. Dopamine-sensitive adenylyl cyclase: possible role in synaptic transmission. Science 1971;174:1346-1349.
130. Onali P, Olianas MC, Gessa GL. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Mol Pharmacol 1985;28:138-145.
131. 2 dopamine receptor cDNA. Nature 1988;336:783-787.
132. 2 dopamine receptor. Proc Natl Acad Sci USA 1989;86:9762-9766.
133. 2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 1989;45:778-785.
134. Egeland JA, Gerhard DS, Pauls DL et al. Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 1987;325:783-787.
135. Hill SY, Goodwin DW, Cadoret R, Osterland CK, Doner SM. Association and linkage between alcoholism and eleven serological markers. J Stud Alcohol 1975;36:981-992.
136. Shigeta Y, Ishii H, Takagi S, et al. HLA antigens as immunogenetic markers of alcoholism and alcoholic liver disease. Pharmacol Biochem Behav 1980;13:89-94.
137. Hill SY, Armstrong J, Steinhauer SR, Baughman T, Zubin J. Static ataxia as a psychobiological marker for alcoholism. Alcohol Clin Exp Res 1987;11:345-348.
138. O'Dowd BF. Structures of dopamine receptors. J Neurochem 1993;60:804-816.
139. 3) as a target for neuroleptics. Nature 1990;347:146-151.
140. 4 receptor with high affinity for the antipsychotic clozapine. Nature 1991;350:610-614.
141. 2 receptor gene in alcoholism. J Am Med Assoc 1990;263:2055-2060.
142. 2 dopamine receptor gene with severe alcoholism. Alcohol 1991;8:409-416.
143. 2 receptor locus as a modifying gene in neuropsychiatric disorders. J Am Med Assoc 1991;266:1793-1800.
144. 2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991;48:648-654.
145. 2 dopamine receptor Al allele. Am J Hum Genet 1994;54:658-668.
146. Begleiter H, Porjesz B, Bihari B, Kissin B. Event-related brain potentials in boys at risk for alcoholism. Science 1984;225:1493-1496.
147. 2 dopamine receptor Al allele. Behav Genet 1995;25:45-58.
148. 2 receptor gene and alcoholism. J Am Med Assoc 1990;264:3156-3160.
149. Parsian A, Todd RD, Devor EJ, et al. Alcoholism and alleles of the human D2 dopamine receptor locus. Studies of association and linkage. Arch Gen Psychiatry 1991;48:655-663.
150. Gelernter J, O'Malley S, Risch N, et al. No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. J Am Med Assoc 1991;266:1801-1807.
151. Cook BL, Wang ZW, Crowe RR, Hauser R, Freimer M. Alcoholism and the D2 receptor gene. Alcohol Clin Exp Res 1992;16:806-809.
152. Gejman PV, Ram A, Gelernter J, et al. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. J Am Med Assoc 1994;271:204-208.
153. Noble EP, Paredes A. Molecular biology and behavior. In: Galanter M, ed. Recent developments in alcoholism. Vol 11: Ten years of progress. New York: Plenum Press, 1993;345-362.
154. Turner E, Ewing J. Shilling P. et al. Lack of association between an RFLP near the D2 dopamine receptor gene and severe alcoholism. Biol Psychiatry 1992;31:285-290.
155. Kidd KK. Associations of disease with genetic markers: déjà vu all over again. Am J Med Genet 1993;48:71-73.
156. Noble EP. The D2 dopamine receptor gene: a review of association studies in alcoholism. Behav Genet 1993;23:119-129.
157. Blum K. Noble EP. The sobering D2 story. Science 1994;265:1346-1347.
158. Goodman RM. A gene for alcohol toxicity, not drinking behavior. Med Hypotheses 1992;38:203-205.
159. George SR, Cheng R, Nguyen T. Israel Y, O'Dowd BF. Polymorphisms of the D4 dopamine receptor alleles in chronic alcoholism. Biochem Biophys Res Commun 1993;196:107-114.
160. Goldman D. Dean M, Brown GL, et al. D2 dopamine receptor genotype and cerebrospinal fluid homovanillic acid. 5-hydroxyindoleacetic acid and 3-methoxy-4-hydroxyphenylglycol in alcoholics in Finland and the United States. Acta Psychiatr Scand 1992;86:351-357.
161. Amadeo S, Fourcade ML, Waksman G. et al. A positive association study between a D2 receptor gene polymorphism and alcoholism. In: Genetics and Alcohol-Related Diseases. International Society for Biomedical Research on Alcoholism 1992 Satellite Symposium, Bordeaux, France, June 18-19, p. 39 (abstr.).
162. Arinami T. Itokawa M, Komiyama T, et al. Association between severity of alcoholism and the Al allele of the dopamine D2 receptor gene TaqI A RFLP in Japanese. Biol Psychiatry 1993;33:108-114.
163. Barr CL, Kidd KK. Population frequencies of the Al allele at the dopamine receptor locus. Biol Psychiatry 1993;34:204-209.
164. Goldman D, Brown GL, Albaugh B, et al. DRD2 dopamine receptor genotype, linkage disequilibrium, and alcoholism in American Indians and other populations. Alcohol Clin Exp Res 1993;17:199-204.
165. Lander E. 'Plenary session, International Congress of Human Genetics.' Washington, DC, 1991.
166. Crowe RR. Candidate genes in psychiatry: an epidemiological perspective. Am J Med Genet 1993;48:74-77.
167. Sutcliffe JG. mRNA in the mammalian central nervous system. Annu Rev Neurosci 1988;11:157-198.
168. Pato CN, Macciardi F, Pato MT, Verga M, Kennedy JL. Review of the putative association of dopamine D2 receptor and alcoholism: a meta-analysis. Am J Med Genet 1993;48:78-82.
169. 2. A bar-room brawl over an alcoholism gene. Sci Am 1992;266:29-32.
170. 2 receptor gene. Genomics 1991;10:527-530.
171. Blum K, Noble EP, Sheridan PJ, et al. Genetic predisposition in alcoholism: association of the D2 dopamine receptor TaqI Bl RFLP with severe alcoholics. Alcohol 1993;10:59-67.
172. Suarez BK, Parsian A, Hampe CL, Todd RD, Reich T, Cloninger CR. Linkage disequilibrium at the D2 dopamine receptor locus (DRD2) in alcoholics and controls. Genomics 1994;19:12-20.
173. Adamson MD. Kennedy J, Petronis A, et al. DRD4 dopamine receptor genotype and CSF monoamine metabolites in Finnish alcoholics and controls. Am J Med Genet 1995;60:199-205.
174. Tran VT, Snyder SH, Major LF, Hawley RJ. GABA receptors are increased in brains of alcoholics. Ann Neurol 1981;9:289-292.
175. Coffman JA. Petty F. Plasma GABA levels in chronic alcoholics. Am J Psychiatry 1985;142:1204-1205.
176. Moss HB. Yao JK, Burns M, Maddock J, Tarter RE. Plasma GABA-like activity in response to ethanol challenge in men at high risk for alcoholism. Biol Psychiatry 1990;27:617-625.
177. Tabakoff B, Hoffman FL, Lee JM, Saito T, Willard B, DeLeon-Jones F. Differences in platelet enzyme activity between alcoholics and non-alcoholics. N Engl J Med 1988;318:134-139.
178. Devor EJ. Cloninger CR, Hoffman PL, Tabakoff B. Adenylate cyclase activity in the families of alcoholics is controlled by a single major gene. Alcohol Alcohol 1991;1:157-160.
179. Devor EJ, Cloninger CR, Hoffman PL, Tabakoff B. A genetic study of platelet adenylate cyclase activity: evidence for a single major locus effect in fluoride-stimulated activity. Am J Hum Genet 1991;49:372-377.
180. Diamond I, Wrubel B, Estrin W, Gordon A. Basal and adenosine receptor-stimulated levels of cyclic AMP are reduced in lymphocytes from alcoholic patients. Proc Natl Acad Sci USA 1987;84:1413-1416.
181. 2 alpha and decreased activity of adenylyl cyclase in lymphocytes of abstinent alcoholics. Alcohol Clin Exp Res 1993;17:315-320.
182. Boismare F, Lhuintre JP, Daoust M, Moore N, Saligaut C, Hillemand B. Platelet affinity for serotonin is increased in alcoholics and former alcoholics: A biological marker for dependence? Alcohol Alcohol 1987;22:155-159.
183. Daoust M, Lhuintre JP, Ernouf D, Legrand E, Breton P, Boucly P. Ethanol intake and 3H-serotonin uptake II: a study in alcoholic patients using platelets 3H-paroxetine binding. Life Sci 1991;48:1977-1983.
184. Ernouf D, Compagnon P, Lothion P, Narcisse G, Bernard JY, Daoust M. Platelets 3H 5-HT uptake in descendants from alcoholic patients: a potential risk factor for alcohol dependence? Life Sci 1993;52:989-995.
185. Schuckit MA. Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry 1994;151:184-189.
186. Goldman D. Genetic transmission. In: Galanter M, ed. Recent developments in alcoholism. Volume 11: Ten years of progress. New York: Plenum Press, 1993;231-248.
187. Polich J, Pollock VE, Bloom FE. Meta-analysis of P300 amplitude from males at risk for alcoholism. Psychol Bull 1994;115:55-73.
188. Schuckit MA, Gold EO, Croot K, Finn P, Polich J. P300 latency after ethanol ingestion in sons of alcoholics and in controls. Biol Psychiatry 1988;24:310-315.
189. Pfefferbaum A, Ford JM, White PM, Mathalon D. Event related potentials in alcoholic men: P3 amplitude reflects family history but not alcohol consumption. Alcohol Clin Exp Res 1991;15:839-850.
190. Hill SY, Steinhauer SR, Park J, Zubin J. Event-related potential characteristics in children of alcoholics from high density families. Alcohol Clin Exp Res 1990;14:6-16.
191. Ehlers CL, Schuckit MA. Evaluation of EEG alpha activity in sons of alcoholics. Neuropsychopharmacology 1991;4:199-205.
192. Pollock VE, Volavka J, Goodwin DW et al. The EEG after alcohol administration in men at risk for alcoholism. Arch Gen Psychiatry 1983;40:857-861.
193. Cohen HL, Porjesz B, Begleiter H. The effects of ethanol on EEG activity in males at risk for alcoholism. Electroencephalogr Clin Neurophysiol 1993;86:368-376.
194. Pollock VE, Earleywine M, Gabrielli WF. Personality and EEG beta in older adults with alcoholic relatives. Alcohol Clin Exp Res 1995;19:37-43.
195. Gabrielli WF, Mednick SA, Volavka J, Pollock VE, Schulsinger F, Itil TM. Electroencephalograms in children of alcoholic fathers. Psychophysiology 1982;19:404-407.
196. Wilkins JN, Gorelick DA, Nademanee K, Taylor A, Herzberg DS. Hypothalamic-pitu-itary function during alcohol exposure and withdrawal and cocaine exposure. In: Galanter M, ed. Recent developments in alcoholism, Vol. 10: Alcohol and cocaine: similarities and differences. New York: Plenum Press, 1992;57-70.
197. Holsboer F, Spengler D. Heuser I. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. In: Swaab DF, Hofman MA, Mirmiran M, Ravid R. van Leeuwen FW, eds. Progress in brain research, Vol. 93. Amsterdam: Elsevier. 1992;385-417.
198. Holsboer F. Psychiatric implications of altered limbic-hypothalamic-pituitary-adreno-cortical activity. Eur Arch Psychiatry Neurol Sci 1989;238:302-322.
199. Lex BW, Ellingboe JE, Teoh SK, Mendelson JH, Rhoades E. Prolactin and cortisol levels following acute alcohol challenges in women with and without a family history of alcoholism. Alcohol 1991;8:383-387.
200. Dettling M, Heinz A, Dufeu P, Rommelspacher H, Graf KJ, Schmidt LG. Dopamin-ergic responsivity in alcoholism; trait, state, or residual marker? Am J Psychiatry 1995;152:1317-1321.
201. Ozawa H, Katamura Y, Hatta S et al. Alterations of guanine nucleotide-binding proteins in post-mortem human brain in alcoholics. Brain Res 1993;620:174-179.
202. Valverius P, Hogstrom-Brandt AM, Borg S. Norepinephrine metabolite in CSF correlates with ethanol consumption and heredity in humans. Alcohol 1993;10:499-503.
203. Moss HB, Yao JK, Burns M, Maddock J, Tarter RE. Plasma GABA-like activity in response to ethanol challenge in men at high risk for alcoholism. Biol Psychiatry 1990;27:617-625.
204. Chen HT, Casanova MF, Kleinman JE, Zito M, Goldman D, Linnoila M. 3H-paroxetine binding in brains of alcoholics. Psychiatry Res 1991;38:293-299.
205. A receptors in the actions of alcohol and in alcoholism: recent advances. Alcohol Alcohol 1994;29:115-129.
206. Volkow ND, Wang GJ, Begleiter H et al. Regional brain metabolic response to lorazepam in subjects at risk for alcoholism. Alcohol Clin Exp Res 1995;19:510-516.
207. Hellstrom-Lindahl E, Winblad B, Nordberg A. Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics. Brain Res 1993;620:42-48.
208. Christa L. Zarski J-P, Nalpas B, Augereau C, Bréchot C. Nested polymerase chain reaction on cellular DNA in plasma: a rapid method to investigate the collagen type I A2 MspI polymorphic restriction site in alcoholic patients. Hum Genet 1992;88:537-540.
209. Woody G, Schuckit M, Weinrieb R, Yu E. A review of the substance use disorders section of the DSM-IV. Psychiatr Clin North Am 1993;16:21-32.
210. Gorman DM. Using theory and basic research to target primary prevention programs: recent developments and future prospects. Alcohol Alcohol 1992;27:583-594.
211. Norstrom T. Prevention strategies and alcohol policy. Addiction 1995;90:515-524.
212. Kumpfer KL, Hopkins R. Prevention; current research and trends. Psychiatr Clin North Am 1993;16:11-32.
213. Shaw GK, Majumdar SK, Waller S, MacGarvie J, Dunn G. Tiapride in the long-term management of alcoholics of anxious or depressive temperament. Br J Psychiatry 1987;164-168.
214. Borg V. Bromocriptine in the prevention of alcohol abuse. Acta Psychiatr Scand 1983;68:100-110.
215. Carlsson C, Fasth BG. A comparison of the effects of propranolol and diazepam in alcoholics. Br J Addict 1976;71:321-326.
216. Gorelick DA. Effect of fluoxetine on alcohol consumption in male alcoholics. Alcoholism 1986;10:113.
217. Naranjo CA. Kadlec KE, Sanhueza P, Woodley-Remus D. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 1990;47:490-498.
218. Naranjo CA, Sellers EM, Lawrin MO. Modulation of ethanol intake by serotonin uptake inhibitors. J Clin Psychiatry 1986;47:16-22.
219. Lhuintre JP, Moore N, Tran G et al. Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol 1990;25:613-622.
220. Kranzler HR, Del Boca F. Babor TF et al. Buspirone vs. placebo in anxious alcoholics. Presented at the 145th Annual Meeting of the American Psychology Association, Washington, June 1992.
221. American Psychiatric Association. Practice guidelines for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. Am J Psychiatry 1995;152 (suppl 11):1-59.
222. Fuller RK, Branchey L, Brightwell DR et al. Disulfiram treatment of alcoholism: a Veterans Administration cooperative study. J Am Med Assoc 1986;256:1449-1455.
223. Volpicelli JR, Alterman AI, Hagashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992;49:876-880.
224. O'Malley SS, Jaffe A, Chang G, Schottenfeld RS. Meyer RE, Rounsaville BJ. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 1992;49:881-887.
225. O'Malley SS. Integration of opioid antagonists and psychosocial therapy in the treatment of narcotic and drug dependence. J Clin Psychiatry 1995;56 (suppl 7):30-38.
226. Swift RM. Effect of naltrexone on human alcohol consumption. J Clin Psychiatry 1995;56(suppl 7):24-29.
227. Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP. Effect of naltrexone on alcohol 'high' in alcoholics. Am J Psychiatry 1995;152:613-615.
228. Volpicelli JR, Clay KL, Watson NT, O'Brien CP. Naltrexone in the treatment of alcoholism: predicting response to naltrexone. J Clin Psychiatry 1995;56(suppl 7):39-44.
229. Lawford BR, Young RM, Rowell JA et al. Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor Al allele. Nat Med 1995;1:337-341.
230. Holder HD, Hallan JB. Impact of alcoholism treatment on total health care costs: a six year study. Adv Alcohol Subst Abuse 1986;6:1-15.
231. Gunby P. Nation's expenditures for alcohol, other drugs, in terms of therapy, prevention now exceeds $1.6 billion. J Am Med Assoc 1987;258:2023.
232. Wing DM, Gay G. A critical literature review of alcoholism treatment cost-benefit/effectiveness. J Nurs Qual Assur 1991;5:28-40.